Study on the value of improved urinary control technology in patients with benign prostatic hyperplasia / 中国医师进修杂志

ABSTRACT

Objective:To explore the application effect of improved urinary control technology in patients with benign prostatic hyperplasia (BPH).Methods:A total of 83 BPH patients admitted to Taihe County People′s Hospital of Anhui Province from June 2017 to August 2020 were selected and divided into the control group (41 cases) and the observation group (42 cases) by a random number table. The control group performed transurethral plasma kinetic enucleation of prostate (PKEP), and the observation group performed modified urinary control technology. The general conditions of surgery, voiding function, urinary control function, sexual function and complication rate were compared between the two groups.Results:Compared with the control group, theoperation time in the observation group was longer and the postoperative hospital stay was shorter (78.67 ± 20.04) min vs. (69.52 ± 18.66) min, (8.64 ± 2.66) d vs. (10.95 ± 3.01) d, there were statistical differences ( P<0.05). The postvoid residual (PVR) and the maximum flow rate (Q max) in the two groups at 1 month and 3 months after operation had no significant differences ( P>0.05). The incidence of urinary incontinence in the observation group at 24 h, 1 week, and 2 weeks after extubation were lower than those in the control group 11.90%(5/42) vs. 36.59% (15/41), 4.76%(2/42) vs. 21.95%(9/41), 2.38%(1/42) vs. 19.51%(8/41), there were statistically differences ( P<0.05). After operation for 3 months, the total incidence of adverse events in the observation group was lower than that in the control group 4.76% (2/42) vs. 19.51% (8/41), P<0.05. Conclusions:The improved urinary control technology has a significant application effect in BPH patients. It can effectively improve the patient′s urination function, protect urinary control and sexual function.